Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

NCT00470327 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00470327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00470327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2005
Completion date
December 31, 2030
Enrollment
4,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue disorder, idiopathic pulmonary fibrosis, interstitial lung diseases, sarcoidosis